Dear Subscriber,
Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Women With HER2-Positive Breast Cancer Should Be Treated Aggressively, Researchers Report
http://www.medicalnewstoday.com/articles/133345.php
Women with breast cancer who test positive for the HER2 gene -- one of the most aggressive forms of the disease -- should be treated aggressively after surgery, even in cases where present tumors are very small, researchers said Friday at the <A href="http://www.
Aromasin (exemestane) Shows Some Advantages Over Tamoxifen As Adjuvant Therapy In Early Breast Cancer; First Results Of The TEAM Trial
http://www.medicalnewstoday.com/articles/133281.php
Interim findings of the TEAM (Tamoxifen Exemestane Adjuvant Multicenter) trial reported on 11th December at the 2008 San Antonio Breast Cancer Symposium (SABCS) suggest women with early invasive breast cancer can expect fewer breast cancer recurrences and a longer time to the occurrence of distant metastases if they are treated with the aromatase inhibitor Aromasin (exemestane) rather than the standard adjuvant therapy tamoxifen after initial therapy (surgery plus chemotherapy and/or radiotherapy).
How Tamoxifen Prevents Breast Cancer In Some Women But Not Others
http://www.medicalnewstoday.com/articles/133260.php
The power of the drug tamoxifen to reduce breast density is key in preventing breast cancer - according to a presentation in America by Cancer Research UK scientists. Researchers monitored the extent to which tamoxifen could reduce breast density in 7000 healthy post menopausal women who are at high risk of breast cancer in a trial called IBIS 1.
New Research Moves Us One Step Closer To Personalised Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/133259.php
CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs. The research shows that women who have a duplication of chromosome 17 in their tumour will benefit from anthracycline drugs, while others can be spared the side-effects of the treatment.
Breast Cancer Recurrence In Women Without Hot Flashes May Be Reduced By Diet
http://www.medicalnewstoday.com/articles/133215.php
A secondary analysis of a large, multicenter clinical trial has shown that a diet loaded with fruits, vegetables and fiber and somewhat lower in fat compared to standard federal dietary recommendations cuts the risk of recurrence in a subgroup of early-stage breast cancer survivors - women who didn't have hot flashes - by approximately 31 percent.
Abraxis BioScience Launches Abraxane(R) In European Union
http://www.medicalnewstoday.com/articles/133195.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion.
Study Throws Light On How Pregnancy And Lactation Affects Cancer Outcomes
http://www.medicalnewstoday.com/articles/133183.php
Being diagnosed with cancer during pregnancy or while breastfeeding is not associated with increased risk of cancer-related death - with the exception of breast and ovarian cancer diagnosed during lactation, according to a study of women in Norway.
Computer-Aided Mammography Finds More Cancer, More False Positives
http://www.medicalnewstoday.com/articles/133168.php
Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false-positive results, which can lead to biopsies in healthy women, according to a recent systematic review.
----------------------------------------------
** CANCER / ONCOLOGY News **
New Tool Could Unpick Complex Cancer Causes & Help Sociologists Mine Facebook
http://www.medicalnewstoday.com/articles/133298.php
Researchers at the University of Warwick's Department of Statistics and Centre for Complexity Science have devised a new research tool that could help unpick the complex cell interactions that lead to cancer and also allow social scientists to mine social networking sites such as Facebook for useful insights.
Researchers Identify New Anti Tumor Gene
http://www.medicalnewstoday.com/articles/133288.php
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.
Aromasin (exemestane) Shows Some Advantages Over Tamoxifen As Adjuvant Therapy In Early Breast Cancer; First Results Of The TEAM Trial
http://www.medicalnewstoday.com/articles/133281.php
Interim findings of the TEAM (Tamoxifen Exemestane Adjuvant Multicenter) trial reported on 11th December at the 2008 San Antonio Breast Cancer Symposium (SABCS) suggest women with early invasive breast cancer can expect fewer breast cancer recurrences and a longer time to the occurrence of distant metastases if they are treated with the aromatase inhibitor Aromasin (exemestane) rather than the standard adjuvant therapy tamoxifen after initial therapy (surgery plus chemotherapy and/or radiotherapy).
Colonoscopy Significantly Reduces Death From Left-Sided Colon Cancer But Not From Right-Sided Colon Cancer
http://www.medicalnewstoday.com/articles/133265.php
A new study finds that colonoscopy is strongly associated with fewer deaths from colorectal cancer. However, the risk reduction appears to be entirely due to a reduction in deaths from left-sided cancers.
How Tamoxifen Prevents Breast Cancer In Some Women But Not Others
http://www.medicalnewstoday.com/articles/133260.php
The power of the drug tamoxifen to reduce breast density is key in preventing breast cancer - according to a presentation in America by Cancer Research UK scientists. Researchers monitored the extent to which tamoxifen could reduce breast density in 7000 healthy post menopausal women who are at high risk of breast cancer in a trial called IBIS 1.
New Research Moves Us One Step Closer To Personalised Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/133259.php
CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs. The research shows that women who have a duplication of chromosome 17 in their tumour will benefit from anthracycline drugs, while others can be spared the side-effects of the treatment.
The American Brain Tumor Association (ABTA) Offers Tips For Coping With Holiday Stress, Emotions
http://www.medicalnewstoday.com/articles/133198.php
If you are living with a brain tumor, caring for someone with a brain tumor or other serious illness, or have recently lost a family member or close friend, the holidays can be stressful, overwhelming, and difficult.
Abraxis BioScience Launches Abraxane(R) In European Union
http://www.medicalnewstoday.com/articles/133195.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion.
Lung Cancer Screening Feasibility Study Funded
http://www.medicalnewstoday.com/articles/133182.php
A study to assess the feasibility of undertaking a UK-based screening trial for lung cancer has been commissioned by the National institute for Health Research Health Technology Assessment (NIHR HTA) programme.
Pre-Existing Diabetes For Persons Diagnosed With Cancer Associated With Increased Risk Of Death
http://www.medicalnewstoday.com/articles/133092.php
Patients with diabetes at the time of a cancer diagnosis have an increased risk of death compared to patients without diabetes, according to a meta-analysis of studies reported in the December 17 issue of<i> JAMA.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Quality Colonoscopy Exam Remains Best Strategy For Detection Of Polyps And Cancers
http://www.medicalnewstoday.com/articles/133284.php
Publication of a Canadian study on colonoscopy's impact on reducing colon cancer deaths suggests a lower impact on mortality than previously reported. Physician experts from the American College of Gastroenterology urge patients and the public to recognize that even if the assumptions and design of this case-control study have produced accurate data, colonoscopy remains the best available option for detection of precancerous colon polyps and the only test with the potential to prevent colorectal cancer by removing these growths.
ASGE Urges Patients To Seek A Qualified Endoscopist Before Undergoing A Colonoscopy For Colorectal Cancer
http://www.medicalnewstoday.com/articles/133282.php
A study released in the Annals of Internal Medicine found that colonoscopy is associated with lower death rates from colorectal cancer, however, the procedure missed lesions more often on the right side of the colon versus the left side.
Colonoscopy Significantly Reduces Death From Left-Sided Colon Cancer But Not From Right-Sided Colon Cancer
http://www.medicalnewstoday.com/articles/133265.php
A new study finds that colonoscopy is strongly associated with fewer deaths from colorectal cancer. However, the risk reduction appears to be entirely due to a reduction in deaths from left-sided cancers.
Racial Gap Growing In Colorectal Cancer According To New Report
http://www.medicalnewstoday.com/articles/133237.php
A new report from the American Cancer Society says despite unprecedented progress in reducing incidence and death rates from colorectal cancer, the gap between blacks and whites continues to grow.
Mapping New Path To Colon Cancer Therapy
http://www.medicalnewstoday.com/articles/133217.php
University of Texas Medical Branch at Galveston researchers have identified a promising new target in the battle against colorectal cancer - a biochemical pathway critical to the spread of tumors to new locations in the body.
Smoking Associated With Increased Risk For Colorectal Cancer And Death
http://www.medicalnewstoday.com/articles/133093.php
An analysis of previous studies indicates that smoking is significantly associated with an increased risk for colorectal cancer and death, according to an article in the December 17 issue of <i>JAMA.
----------------------------------------------
** LUNG CANCER News **
Largest Ever Prostate Cancer Screening Program In USA Shows High Compliance And Consistent Results
http://www.medicalnewstoday.com/articles/133213.php
Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the urology journal <i>BJU International.
Lung Cancer Screening Feasibility Study Funded
http://www.medicalnewstoday.com/articles/133182.php
A study to assess the feasibility of undertaking a UK-based screening trial for lung cancer has been commissioned by the National institute for Health Research Health Technology Assessment (NIHR HTA) programme.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Preventing A Recurrence Of The Northwick Park Trial
http://www.medicalnewstoday.com/articles/133211.php
Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.
One Step Closer To A Treatment For Mixed-Lineage Leukemia
http://www.medicalnewstoday.com/articles/133188.php
Infants and adults with the blood cancer mixed-lineage leukemia (MLL) typically have a poor prognosis, and most infants die before their first birthdays. Although there are varying causes of MLL, most cases are caused by a fusion of two genes, the MLL and the AF4 genes.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System In Robotic Assisted Prostate Surgery Study
http://www.medicalnewstoday.com/articles/133286.php
.Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., announced enrollment of the first patient in a study of Hypothermic Radical Prostatectomybeing conducted by researchers at the University of California, Irvine.
Largest Ever Prostate Cancer Screening Program In USA Shows High Compliance And Consistent Results
http://www.medicalnewstoday.com/articles/133213.php
Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the urology journal <i>BJU International.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
